Direct Thrombus Imaging in Stroke

키워드

참고문헌 (65)

1. Mozaffarian D, "Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association", Circulation, 133, pp.e38~e360 (2016)
2. Kirmani JF, "Advances in thrombolytics for treatment of acute ischemic stroke", Neurology, 79, pp.S119~S125 (2012)
3. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, "Tissue plasminogen activator for acute ischemic stroke", N Engl J Med, 333, pp.1581~1587 (1995)
4. Adibhatla RM, "Tissue plasminogen activator(tPA)and matrix metalloproteinases in the pathogenesis of stroke : therapeutic strategies", CNS Neurol Disord Drug Targets, 7, pp.243~253 (2008)
5. Gravanis I, "Tissue-type plasminogen activator as a therapeutic target in stroke", Expert Opin Ther Targets, 12, pp.159~170 (2008)
6. Guerrero WR, "Defining intravenous recombinant tissue plasminogen activator failure", Stroke, 44, pp.819~821 (2013)
7. Kim DE, "Hyperacute direct thrombus imaging using computed tomography and gold nanoparticles", Ann Neurol, 73, pp.617~625 (2013)
8. Anderson CS, "Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke", N Engl J Med, 374, pp.2313~2323 (2016)
9. Jaberi A, "Computed tomography angiography intraluminal filling defect is predictive of internal carotid artery free-floating thrombus", Neuroradiology, 56, pp.15~23 (2014)
10. Kim JY, "Direct Imaging of Cerebral Thromboemboli Using Computed Tomography and Fibrin-targeted Gold Nanoparticles", Theranostics, 5, pp.1098~1114 (2015)
11. 이동근, "Will Molecular Optical Imaging Have Clinically Important Roles in Stroke Management, and How?", Journal of Clinical Neurology, 6(1), pp.10~18 (2010), 대한신경과학회
12. Kim DE, "Direct thrombus imaging as a means to control the variability of mouse embolic infarct models : the role of optical molecular imaging", Stroke, 42, pp.3566~3573 (2011)
13. Kramer MC, "Relationship of thrombus healing to underlying plaque morphology in sudden coronary death", J Am Coll Cardiol, 55, pp.122~132 (2010)
14. Young L, "Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality", J Thromb Haemost, 4, pp.1919~1924 (2006)
15. Kearon C, "Natural history of venous thromboembolism", Circulation, 107, pp.122~130 (2003)
16. Ahn SG, "The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction", Coron Artery Dis, 26, pp.245~253 (2015)
17. Chueh JY, "Reduction in distal emboli with proximal flow control during mechanical thrombectomy : a quantitative in vitro study", Stroke, 44, pp.1396~1401 (2013)
18. Gobin YP, "MERCI 1 : a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia", Stroke, 35, pp.2848~2854 (2004)
19. Applegate RJ, "Optimal therapy for ST-segment elevation myocardial infarction : the role of residual thrombus", J Am Coll Cardiol, 57, pp.1874~1876 (2011)
20. Overoye-Chan K, "EP-2104R : a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus", J Am Chem Soc, 130, pp.6025~6039 (2008)
21. Uppal R, "Molecular MRI of intracranial thrombus in a rat ischemic stroke model", Stroke, 41, pp.1271~1277 (2010)
22. Walter J, "Textbook of Interventional Cardiovascular Pharmacology: Chapter 1 An overview of hemostasis and thrombosis", pp.1~29 (2007), CRC Press
23. Burke AP, "Coronary risk factors and plaque morphology in men with coronary disease who died suddenly", N Engl J Med, 336, pp.1276~1282 (1997)
24. Crouse JR, 3rd, "Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery", Circulation, 92, pp.1141~1147 (1995)
25. Virmani R, "Vulnerable plaque : the pathology of unstable coronary lesions", J Interv Cardiol, 15, pp.439~446 (2002)
26. JM UK-I, "Carotid-artery imaging in the diagnosis and management of patients at risk of stroke", Lancet Neurol, 8, pp.569~580 (2009)
27. Nighoghossian N, "The vulnerable carotid artery plaque : current imaging methods and new perspectives", Stroke, 36, pp.2764~2772 (2005)
28. Yuan C, "Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization", J Magn Reson Imaging, 15, pp.62~67 (2002)
29. Glagov S, "Compensatory enlargement of human atherosclerotic coronary arteries", N Engl J Med, 316, pp.1371~1375 (1987)
30. Flacke S, "Novel MRI contrast agent for molecular imaging of fibrin : implications for detecting vulnerable plaques", Circulation, 104, pp.1280~1285 (2001)
31. Lindner JR, "Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes", Circulation, 102, pp.2745~2750 (2000)
32. Weinberger J, "A new noninvasive technique for imaging atherosclerotic plaque in the aortic arch of stroke patients by transcutaneous real-time B-mode ultrasonography : an initial report", Stroke, 29, pp.673~676 (1998)
33. Corti R, "In vivo noninvasive detection and age definition of arterial thrombus by MRI", J Am Coll Cardiol, 39, pp.1366~1373 (2002)
34. Edelman RR, "Fast selective black blood MR imaging", Radiology, 181, pp.655~660 (1991)
35. Song HK, "Multislice double inversion pulse sequence for efficient black-blood MRI", Magn Reson Med, 47, pp.616~620 (2002)
36. Johnstone MT, "In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model", Arterioscler Thromb Vasc Biol, 21, pp.1556~1560 (2001)
37. Botnar RM, "In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent", Circulation, 109, pp.2023~2029 (2004)
38. Viereck J, "MRI of atherothrombosis associated with plaque rupture", Arterioscler Thromb Vasc Biol, 25, pp.240~245 (2005)
39. Moody AR, "Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia", Circulation, 107, pp.3047~3052 (2003)
40. Weisstanner C, "Thrombus imaging in acute stroke : correlation of thrombus length on susceptibility-weighted imaging with endovascular reperfusion success", Eur Radiol, 24, pp.1735~1741 (2014)
41. von zur Muhlen C, "Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis", Circulation, 118, pp.258~267 (2008)
42. von Elverfeldt D, "Dual-contrast molecular imaging allows noninvasive characterization of myocardial ischemia", reperfusion injury after coronary vessel occlusion in mice by magnetic resonance imaging, 2014, pp.130, 676~687
43. Heidt T, "Molecular Imaging of Activated Platelets Allows the Detection of Pulmonary Embolism with Magnetic Resonance Imaging", Sci Rep, 6, pp.25044~ (2016)
44. Kim DE, "Primer on cerebrovascular diseases", Elsevier
45. Bunevicius A, "The potential roles of 18F-FDG-PET in management of acute stroke patients", Biomed Res Int, 2013, pp.634598~ (2013)
46. Aziz K, "Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography", positron emission tomography, 2008, pp.117, 2061~2070
47. Hara T, "18F-fluorodeoxyglucose positron emission tomography", computed tomography enables the detection of recurrent same-site deep vein thrombosis by illuminating recently formed, neutrophil-rich thrombus, 2014, pp.130, 1044~1052
48. Ciesienski KL, "Fibrin-targeted PET probes for the detection of thrombi", Mol Pharm, 10, pp.1100~1110 (2013)
49. Blasi F, "Effect of Chelate Type and Radioisotope on the Imaging Efficacy of 4 Fibrin-Specific PET Probes", J Nucl Med, 55, pp.1157~1163 (2014)
50. Blasi F, "Multisite Thrombus Imaging and Fibrin Content Estimation With a Single Whole-Body PET Scan in Rats", Arterioscler Thromb Vasc Biol, 35, pp.2114~2121 (2015)
51. Jha B, "Pearls & oy-sters: hyperdense or pseudohyperdense MCA sign: a Damocles sword?", Neurology, 72, pp.e116~e117 (2009)
52. Liebeskind DS, "CT and MRI early vessel signs reflect clot composition in acute stroke", Stroke, 42, pp.1237~1243 (2011)
53. Aouad P, "Prevalence, Comorbid Associations and Prognostic Value of the Hyperdense Middle Cerebral Artery Sign", ISRN Stroke, 2013, pp.6~ (2013)
54. Mamlouk MD, "Cerebral thromboembolism : value of susceptibility-weighted imaging in the initial diagnosis of acute infarction", Neuroradiol J, 25, pp.45~56 (2012)
55. Grover SP, "Quantification of experimental venous thrombus resolution by longitudinal nanogold-enhanced micro-computed tomography", Thromb Res, 136, pp.1285~1290 (2015)
56. Kim DE, "Combined near-infrared fluorescent imaging and micro-computed tomography for directly visualizing cerebral thromboemboli", J Vis Exp
57. Anderson NG, "Spectroscopic(multi-energy)CT distinguishes iodine and barium contrast material in MICE", Eur Radiol, 20, pp.2126~2134 (2010)
58. Stern ST, "Nanotechnology safety concerns revisited", Toxicol Sci, 101, pp.4~21 (2008)
59. Xie J, "Nanoparticle-based theranostic agents", Adv Drug Deliv Rev, 62, pp.1064~1079 (2010)
60. Sirol M, "Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent", Circulation, 112, pp.1594~1600 (2005)
61. Klink A, "Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probe", Arterioscler Thromb Vasc Biol, 30, pp.403~410 (2010)
62. Wen AM, "Shaping bio-inspired nanotechnologies to target thrombosis for dual optical-magnetic resonance imaging", J Mater Chem B Mater Biol Med, 3, pp.6037~6045 (2015)
63. Gale EM, "A Manganese Alternative to Gadolinium for MRI Contrast", J Am Chem Soc, 137, pp.15548~15557 (2015)
64. Patel R, "Plaque rupture and thrombosis are reduced by lowering cholesterol levels and crystallization with ezetimibe and are correlated with fluorodeoxyglucose positron emission tomography", Arterioscler Thromb Vasc Biol, 31, pp.2007~2014 (2011)
65. Ay I, "In vivo molecular imaging of thrombosis and thrombolysis using a fibrin-binding positron emission tomographic probe", Circ Cardiovasc Imaging, 7, pp.697~705 (2014)

관련 논문AI추천